Potent response of QS-21 as a vaccine adjuvant in the skin when delivered with the Nanopatch, resulted in adjuvant dose sparing
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Potent response of QS-21 as a vaccine adjuvant in the skin when delivered with the Nanopatch, resulted in adjuvant dose sparing
Authors
Keywords
-
Journal
Scientific Reports
Volume 6, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-07-12
DOI
10.1038/srep29368
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Identification of QS-21 as an Inflammasome-activating Molecular Component of Saponin Adjuvants
- (2015) Robyn Marty-Roix et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults
- (2015) Himal Lal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effective and lesion-free cutaneous influenza vaccination
- (2015) Ji Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Vaccine Adjuvant Systems containing monophosphoryl lipid A and QS-21 induce strong humoral and cellular immune responses against hepatitis B surface antigen which persist for at least 4 years after vaccination
- (2015) Geert Leroux-Roels et al. VACCINE
- Immunogenicity and Safety of an Inactivated Quadrivalent Influenza Vaccine in US Children 6–35 Months of Age During 2013–2014: Results From A Phase II Randomized Trial
- (2015) Long Wang et al. Journal of the Pediatric Infectious Diseases Society
- Molecular determinants of sterile inflammation
- (2014) Hajime Kono et al. CURRENT OPINION IN IMMUNOLOGY
- Cutting Edge: Antigen Presentation to CD8 T Cells after Influenza A Virus Infection
- (2014) E. Ingulli et al. JOURNAL OF IMMUNOLOGY
- Colocalization of Cell Death with Antigen Deposition in Skin Enhances Vaccine Immunogenicity
- (2014) Alexandra C.I. Depelsenaire et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Development of a minimal saponin vaccine adjuvant based on QS-21
- (2014) Alberto Fernández-Tejada et al. Nature Chemistry
- Antibody responses to intradermal or intramuscular MF59-adjuvanted influenza vaccines as evaluated in elderly institutionalized volunteers during a season of partial mismatching between vaccine and circulating A(H3N2) strains
- (2014) Barbara Camilloni et al. Immunity & Ageing
- Unusual Patterns of IgG Avidity in Some Young Children following Two Doses of the Adjuvanted Pandemic H1N1 (2009) Influenza Virus Vaccine
- (2013) Karen K. Yam et al. Clinical and Vaccine Immunology
- Adverse events following immunization with vaccines containing adjuvants
- (2013) S. Cerpa-Cruz et al. IMMUNOLOGIC RESEARCH
- Key roles of adjuvants in modern vaccines
- (2013) Steven G Reed et al. NATURE MEDICINE
- Dry-Coated Live Viral Vector Vaccines Delivered by Nanopatch Microprojections Retain Long-Term Thermostability and Induce Transgene-Specific T Cell Responses in Mice
- (2013) Frances E. Pearson et al. PLoS One
- The adjuvant MF59 induces ATP release from muscle that potentiates response to vaccination
- (2013) M. Vono et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Tissue Specific Heterogeneity in Effector Immune Cell Response
- (2013) Saba Tufail et al. Frontiers in Immunology
- Nanopatch targeted delivery of both antigen and adjuvant to skin synergistically drives enhanced antibody responses
- (2012) Germain J.P. Fernando et al. JOURNAL OF CONTROLLED RELEASE
- Induction of potent CD8+ T cell responses through the delivery of subunit protein vaccines to skin antigen-presenting cells using densely packed microprojection arrays
- (2012) Hwee-Ing Ng et al. JOURNAL OF CONTROLLED RELEASE
- Depth-resolved characterization of diffusion properties within and across minimally-perturbed skin layers
- (2012) Anthony P. Raphael et al. JOURNAL OF CONTROLLED RELEASE
- Mixed Adjuvant Formulations Reveal a New Combination That Elicit Antibody Response Comparable to Freund's Adjuvants
- (2012) Rachel P. J. Lai et al. PLoS One
- High density and high aspect ratio solid micro-nanoprojection arrays for targeted skin vaccine delivery and specific antibody extraction
- (2012) Derek Jenkins et al. RSC Advances
- Natural and synthetic saponin adjuvant QS-21 for vaccines against cancer
- (2011) Govind Ragupathi et al. Expert Review of Vaccines
- Recent clinical experience with vaccines using MPL- and QS-21-containing Adjuvant Systems
- (2011) Nathalie Garçon et al. Expert Review of Vaccines
- Improving the reach of vaccines to low-resource regions, with a needle-free vaccine delivery device and long-term thermostabilization
- (2011) Xianfeng Chen et al. JOURNAL OF CONTROLLED RELEASE
- Rapid kinetics to peak serum antibodies is achieved following influenza vaccination by dry-coated densely packed microprojections to skin
- (2011) Xianfeng Chen et al. JOURNAL OF CONTROLLED RELEASE
- First Results of Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African Children
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- MF59 Adjuvant Enhances Diversity and Affinity of Antibody-Mediated Immune Response to Pandemic Influenza Vaccines
- (2011) S. Khurana et al. Science Translational Medicine
- Vaccine adjuvants alum and MF59 induce rapid recruitment of neutrophils and monocytes that participate in antigen transport to draining lymph nodes
- (2011) Samuele Calabro et al. VACCINE
- The effect of strain rate on the precision of penetration of short densely-packed microprojection array patches coated with vaccine
- (2010) Michael L. Crichton et al. BIOMATERIALS
- Vaccine Adjuvants: Putting Innate Immunity to Work
- (2010) Robert L. Coffman et al. IMMUNITY
- Potent Immunity to Low Doses of Influenza Vaccine by Probabilistic Guided Micro-Targeted Skin Delivery in a Mouse Model
- (2010) Germain J. P. Fernando et al. PLoS One
- Vaccines with MF59 Adjuvant Expand the Antibody Repertoire to Target Protective Sites of Pandemic Avian H5N1 Influenza Virus
- (2010) S. Khurana et al. Science Translational Medicine
- Codelivery of adjuvants at the primary immunization site is essential for evoking a robust immune response to neoglycoconjugates
- (2010) Dodi Safari et al. VACCINE
- Dry-coated microprojection array patches for targeted delivery of immunotherapeutics to the skin
- (2009) Xianfeng Chen et al. JOURNAL OF CONTROLLED RELEASE
- Clinical administration of microneedles: skin puncture, pain and sensation
- (2008) M. I. Haq et al. BIOMEDICAL MICRODEVICES
- Estimating teh costs of achieving the WHO-UNICEF Global Immunization Vision and Strategy, 2006-2015
- (2008) Lara Wolfson BULLETIN OF THE WORLD HEALTH ORGANIZATION
- Effect of Microneedle Design on Pain in Human Volunteers
- (2008) Harvinder S. Gill et al. CLINICAL JOURNAL OF PAIN
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started